Simplicity Wealth LLC Buys 62,148 Shares of Waldencast plc (NASDAQ:WALD)

Simplicity Wealth LLC increased its stake in Waldencast plc (NASDAQ:WALD) by 416.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,080 shares of the company’s stock after purchasing an additional 62,148 shares during the period. Simplicity Wealth LLC’s holdings in Waldencast were worth $281,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Renaissance Technologies LLC bought a new stake in shares of Waldencast during the second quarter worth $239,000. Bleakley Financial Group LLC bought a new stake in Waldencast during the 1st quarter worth about $142,000. Norden Group LLC acquired a new position in Waldencast during the 1st quarter valued at about $92,000. Marshall Wace LLP bought a new position in shares of Waldencast in the 2nd quarter valued at about $37,000. Finally, Catalina Capital Group LLC acquired a new stake in shares of Waldencast during the 1st quarter worth approximately $73,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Analyst Ratings Changes

WALD has been the topic of several analyst reports. DA Davidson increased their price objective on shares of Waldencast from $6.50 to $7.25 and gave the company a “buy” rating in a report on Wednesday, September 4th. Telsey Advisory Group restated an “outperform” rating and issued a $6.00 price target on shares of Waldencast in a research report on Wednesday, October 9th.

Waldencast Price Performance

Shares of NASDAQ:WALD opened at $3.32 on Tuesday. The firm’s 50 day simple moving average is $3.41 and its 200 day simple moving average is $4.08. The company has a current ratio of 1.47, a quick ratio of 0.78 and a debt-to-equity ratio of 0.21. Waldencast plc has a fifty-two week low of $2.40 and a fifty-two week high of $12.00.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.